Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

EXAI

Exscientia (EXAI)

Exscientia PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EXAI
DateTimeSourceHeadlineSymbolCompany
12/02/20248:39AMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:EXAIExscientia PLC
11/22/20248:00PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:EXAIExscientia PLC
11/20/202410:01AMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EXAIExscientia PLC
11/20/20249:53AMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:EXAIExscientia PLC
11/20/20249:20AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
11/20/20247:00AMGlobeNewswire Inc.Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discoveryNASDAQ:EXAIExscientia PLC
11/13/202410:37AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
11/12/20244:55PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
11/08/20246:40AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
11/06/20246:08AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
10/24/20244:00PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXAIExscientia PLC
10/16/20249:49PMBusiness WireExscientia franchit des étapes importantes pour deux de ses programmes dans le cadre de sa collaboration avec SanofiNASDAQ:EXAIExscientia PLC
10/16/20249:35PMBusiness WireExscientia erreicht Meilensteine ​​für zwei Programme im Rahmen der Zusammenarbeit mit SanofiNASDAQ:EXAIExscientia PLC
10/16/20247:00AMBusiness WireExscientia Achieves Milestones for Two Programmes in Sanofi CollaborationNASDAQ:EXAIExscientia PLC
10/10/20246:04AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
10/09/20243:25PMBusiness WireExscientia präsentiert auf der ENA 2024 neue präklinische Daten für KI-gestützte LSD1- und MALT1-InhibitorenNASDAQ:EXAIExscientia PLC
10/09/20243:25PMBusiness WireExscientia présentera de nouvelles données précliniques pour les inhibiteurs de la LSD1 et du MALT1 conçus par l'IA à l'ENA 2024NASDAQ:EXAIExscientia PLC
10/09/20247:00AMBusiness WireExscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ENA 2024NASDAQ:EXAIExscientia PLC
08/30/20248:57AMEdgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:EXAIExscientia PLC
08/28/20244:42PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
08/28/202412:11PMBusiness WireExscientia wird auf der 22nd Annual Global Healthcare Conference Präsentation durchführenNASDAQ:EXAIExscientia PLC
08/28/202412:11PMBusiness WireExscientia participera à la 22e conférence annuelle de Morgan Stanley sur les soins médicaux dans le mondeNASDAQ:EXAIExscientia PLC
08/28/20247:00AMBusiness WireExscientia to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:EXAIExscientia PLC
08/23/20244:07PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXAIExscientia PLC
08/15/20247:19AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
08/15/20247:00AMBusiness WireExscientia Business Update for Second Quarter and First Half 2024NASDAQ:EXAIExscientia PLC
08/09/20245:44AMIH Market NewsTSMC July Revenue Surges 45%, Nasdaq Accelerates Penny Stock Delistings, Moody’s Downgrades Intel to BAA1, and MoreNASDAQ:EXAIExscientia PLC
08/08/20245:19PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EXAIExscientia PLC
08/08/20247:39AMGlobeNewswire Inc.Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End CapabilitiesNASDAQ:EXAIExscientia PLC
07/24/20244:06PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXAIExscientia PLC
 Showing the most relevant articles for your search:NASDAQ:EXAI